Neomorph, Novo Nordisk enter $1.46bn partnership focused on molecular glue degraders
Neomorph will receive upfront and near-term milestone payments, R&D funding, and milestone payments, totalling $1.46bn from Novo Nordisk,…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Feb 24
Neomorph will receive upfront and near-term milestone payments, R&D funding, and milestone payments, totalling $1.46bn from Novo Nordisk,…
23 Feb 24
The collaboration to leverage AbbVie's therapeutic area expertise and Tentarix's Tentacles platform, to develop novel multifunctional biologics in…
14 Nov 23
Under the 10-year IDIQ contract, GDIT will install a new cloud-based enterprise EHR system from Oracle Health to…
29 Sep 23
HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…
13 Sep 23
The exclusive licensing partnership agreement provides Astellas with a total of up to €5.5m, in upfront and milestone…
07 Sep 23
The new research alliance will help advance three programmes over the next three years, of which two programmes…
23 Aug 23
The funding under Project NextGen includes $1bn to BARDA partners for vaccine clinical trials, $326m to Regeneron for…
21 Aug 23
The 160-acre site owned by Reliance Life Sciences in Nashik is set to host manufacturing plants dedicated to…
04 Aug 23
The bulk product, worth $96m, will be made and invoiced in 2023, but it will only partially replenish…
06 Jul 23
Under the contract, Evotec Biologics will develop drug product prototype(s) from discovery through the execution of Phase 1…